Daniël Blockmans

16.4k total citations · 3 hit papers
190 papers, 7.7k citations indexed

About

Daniël Blockmans is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Genetics. According to data from OpenAlex, Daniël Blockmans has authored 190 papers receiving a total of 7.7k indexed citations (citations by other indexed papers that have themselves been cited), including 92 papers in Pulmonary and Respiratory Medicine, 81 papers in Rheumatology and 40 papers in Genetics. Recurrent topics in Daniël Blockmans's work include Vasculitis and related conditions (81 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (30 papers) and Otitis Media and Relapsing Polychondritis (28 papers). Daniël Blockmans is often cited by papers focused on Vasculitis and related conditions (81 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (30 papers) and Otitis Media and Relapsing Polychondritis (28 papers). Daniël Blockmans collaborates with scholars based in Belgium, Netherlands and United States. Daniël Blockmans's co-authors include Luc Mortelmans, Herman Bobbaers, Steven Vanderschueren, Wolfgang Schmidt, Bhaskar Dasgupta, Elisabeth Brouwer, Carlo Salvarani, Alex Maes, Hans Deckmyn and Sigrid Stroobants and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.

In The Last Decade

Daniël Blockmans

179 papers receiving 7.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Trial of Tocilizumab in Giant-Cell Arteritis

2017 815 citations Daniël Blockmans et al. profile →
EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice

2018 577 citations Daniël Blockmans et al. Annals of the Rheumatic Diseases profile →
A Phase 3 Trial of Upadacitinib for Giant-Cell Arteritis

2025 16 citations Daniël Blockmans, Ellen‐Margrethe Hauge et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Daniël Blockmans	4.7k	4.1k	1.3k	1.3k	948	190	7.7k
Bernhard Hellmich	4.7k 1.0×	2.9k 0.7×	1.5k 1.2×	1.1k 0.9×	608 0.6×	160	6.2k
Gail S. Kerr	4.6k 1.0×	3.0k 0.7×	1.8k 1.4×	942 0.7×	610 0.6×	114	6.8k
Kenneth J. Warrington	4.5k 1.0×	4.1k 1.0×	620 0.5×	1.4k 1.1×	848 0.9×	254	7.7k
C. G. M. Kallenberg	4.4k 0.9×	3.1k 0.7×	2.2k 1.7×	1.2k 0.9×	855 0.9×	74	7.2k
Xavier Puéchal	3.0k 0.6×	3.3k 0.8×	1.7k 1.3×	897 0.7×	1.1k 1.1×	213	7.1k
Elisabeth Brouwer	4.5k 1.0×	4.6k 1.1×	1.7k 1.3×	1.5k 1.1×	680 0.7×	240	9.4k
Lorraine Harper	5.7k 1.2×	2.7k 0.6×	1.7k 1.3×	2.0k 1.5×	681 0.7×	192	8.3k
María C. Cid	7.3k 1.6×	5.3k 1.3×	1.4k 1.0×	2.2k 1.7×	1.0k 1.1×	204	11.4k
Carlos García‐Porrúa	3.8k 0.8×	4.2k 1.0×	519 0.4×	1.0k 0.8×	551 0.6×	154	6.9k
E. Christiaan Hagen	6.1k 1.3×	2.7k 0.6×	1.9k 1.4×	1.8k 1.4×	485 0.5×	52	7.1k

Countries citing papers authored by Daniël Blockmans

Since Specialization

Citations

This map shows the geographic impact of Daniël Blockmans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniël Blockmans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniël Blockmans more than expected).

Fields of papers citing papers by Daniël Blockmans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniël Blockmans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniël Blockmans. The network helps show where Daniël Blockmans may publish in the future.

Co-authorship network of co-authors of Daniël Blockmans

This figure shows the co-authorship network connecting the top 25 collaborators of Daniël Blockmans. A scholar is included among the top collaborators of Daniël Blockmans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniël Blockmans. Daniël Blockmans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Betrains, Albrecht, et al.. (2025). Validation of the polymyalgia rheumatica-activity score: A prospective cohort study. Seminars in Arthritis and Rheumatism. 72. 152695–152695.

Betrains, Albrecht, et al.. (2024). Comparison of symptoms between diagnosis and relapse in giant cell arteritis: a retrospective cohort study. Lara D. Veeken. 63(12). e325–e327. 3 indexed citations

Blockmans, Daniël, Ellen‐Margrethe Hauge, Helen Keen, et al.. (2024). Efficacité et tolérance d’upadacitinib chez des patients atteints d’artérite à cellules géantes (SELECT-GCA) : essai de phase III contrôlé et randomisé en double aveugle. Revue du Rhumatisme. 91. A81–A82.

Betrains, Albrecht, Catharina M. Mulders‐Manders, Paul G. Auwaerter, et al.. (2024). Comparison of diagnostic spectrum between inflammation of unknown origin and fever of unknown origin: A systematic review and meta-analysis. European Journal of Internal Medicine. 124. 115–121. 4 indexed citations

Vulsteke, Jean‐Baptiste, Frédéric Coutant, David Gonçalves, et al.. (2023). Detection of anti-eIF2B autoantibodies in systemic sclerosis by immunoprecipitation-mass spectrometry. Lara D. Veeken. 62(7). e216–e218. 5 indexed citations

Bossuyt, Xavier, Jean‐Baptiste Vulsteke, Jan Van Elslande, et al.. (2023). Antinuclear antibodies in individuals with COVID-19 reflect underlying disease: Identification of new autoantibodies in systemic sclerosis (CDK9) and malignancy (RNF20, RCC1, TRIP13). Autoimmunity Reviews. 22(4). 103288–103288. 4 indexed citations

Vulsteke, Jean‐Baptiste, Vanessa Smith, Carolien Bonroy, et al.. (2023). Autoantibodies against the NineTeen complex and U5 RNP in systemic sclerosis. Journal of Autoimmunity. 139. 103056–103056. 1 indexed citations

Betrains, Albrecht, et al.. (2023). Diagnostic yield of combined cranial and large vessel PET/CT, ultrasound and MRI in giant cell arteritis: A systematic review and meta-analysis. Autoimmunity Reviews. 22(7). 103355–103355. 24 indexed citations

Betrains, Albrecht, et al.. (2023). Higher diagnostic yield of 18F-FDG PET in inflammation of unknown origin compared to fever of unknown origin. European Journal of Internal Medicine. 110. 71–76. 10 indexed citations

10.

Vulsteke, Jean‐Baptiste, Xavier Bossuyt, Kristl G. Claeys, et al.. (2021). Detection of multiple myositis-specific autoantibodies in unique patients with idiopathic inflammatory myopathy: A single centre-experience and literature review. Seminars in Arthritis and Rheumatism. 51(2). 486–494. 10 indexed citations

11.

Bossuyt, Xavier, Koen Poesen, Kristl G. Claeys, et al.. (2017). FRI0393 Prevalence of myositis-specific antibodies in idiopathic inflammatory myopathy compared to disease and healthy controls. Annals of the Rheumatic Diseases. 76. 636–637. 1 indexed citations

12.

Jayne, David, Daniël Blockmans, Raashid Luqmani, et al.. (2017). Efficacy and Safety of Belimumab in Combination with Azathioprine for Remission Maintenance in Granulomatosis with Polyangiitis and Microscopic Polyangiitis: A Multicenter Randomized, Placebo-Controlled Study. Lirias (KU Leuven). 69. 3 indexed citations

13.

Meyts, Isabelle, et al.. (2012). HEMATOPOIETIC STEM CELL TRANSPLANTATION IN A PATIENT WITH WHIM SYNDROME AND PANCYTOPENIA. Journal of Clinical Immunology. 32. 92–92. 1 indexed citations

14.

Blockmans, Daniël, et al.. (2009). Een 25-jarige man met langdurige koorts en aseptische meningitis. Tijdschrift voor Geneeskunde. 65(16). 754–757. 1 indexed citations

15.

Vanthuyne, Marie, Frédéric Houssiau, Daniël Blockmans, et al.. (2006). Efficacy and safety of a protocol-based treatment of severe early diffuse systemic sclerosis (dSSc) using mycophenolate mofetil (MMF) in combination with intravenous methylprednisolone (IV MP) pulses.. Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)). 54(9). 1 indexed citations

16.

Vanderschueren, Steven, Daniël Knockaert, Tom Adriaenssens, et al.. (2002). From prolonged febrile illness to fever of unknown origin. The challenge continues. Clinical Microbiology and Infection. 9. 11 indexed citations

17.

Blockmans, Daniël. (1995). De ziekte van Wegener. Tijdschrift voor Geneeskunde. 51(7). 509–516. 1 indexed citations

18.

Blockmans, Daniël, et al.. (1991). Commercially available intravenous immunoglobulins (iv igs) inhibit binding of anti-glycoprotein (gp)iib-iiia antibodies to their antigens in chronic idiopathic thrombocytopenic purpura (itp) patients. Thrombosis and Haemostasis. 65(6). 1065–1065. 1 indexed citations

19.

Blockmans, Daniël, et al.. (1986). Naar een internationaal vergelijkbare maatstaf voor de orale antistollingstherapie. Tijdschrift voor Geneeskunde. 42(17). 1143–1146.

20.

Blockmans, Daniël, Paolo Gresele, Hans Deckmyn, & Marc Verstraete. (1985). Influence of products of the cyclo-oxygenase pathway on platelet shape change. Thrombosis and Haemostasis. 54(1). 19–19. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact